“Ebola treatment units remain under severe pressure, with bed occupancy reaching 95 per cent across affected facilities,” Mr Mankoula said.
A major international clinical trial aimed at finding effective treatments for Bundibugyo virus disease, a rare form of Ebola, has commenced in the DRC.
A statement noted that the fund would help African countries and partners to strengthen Ebola preparedness, early detection and rapid response measures.
Tests detected the virus in 13 out of 20 samples.
Gavi said it planned to make malaria vaccines available to 50 million children across Africa by 2030.
Several other African countries are currently reviewing the drug or awaiting regulatory approval for rollout.
Mr Boum II said Africa CDC is working with countries to prioritise cholera hotspots.
Africa CDC and PANTHER plan to expand the trial to additional countries, including Uganda, as enrolment continues.
He said that accelerating local drug production was crucial to building a resilient health ecosystem.
He disclosed plans to establish a regional EOC hub in Abuja.
